Community Investing Ideas

Global Weekly Picks

CA$31.8
FV
98.5% undervalued intrinsic discount
4.4k
users have viewed this narrative
14users have liked this narrative
7users have commented on this narrative
43users have followed this narrative
US$67.5
3.8% overvalued intrinsic discount
AllTrades's Fair Value
Revenue
5.23% p.a.
Profit Margin
27%
Future PE
23.47x
Price in 2028
US$80.97
US$430.14
17.3% undervalued intrinsic discount
TechStonks's Fair Value
Revenue
9% p.a.
Profit Margin
30%
Future PE
21x
Price in 2030
US$648.35
US$10.61
48.7% overvalued intrinsic discount
PittTheYounger's Fair Value
Revenue
2.5% p.a.
Profit Margin
2.5%
Future PE
7x
Price in 2028
US$15.31
€34.58
64.3% undervalued intrinsic discount
kapirey's Fair Value
Revenue
3% p.a.
Profit Margin
5%
Future PE
14x
Price in 2030
€46.61
US$32.8
23.1% overvalued intrinsic discount
RobMorgan3's Fair Value
Revenue
10% p.a.
Profit Margin
8%
Future PE
9x
Price in 2030
US$52.82
US$240.06
22.2% undervalued intrinsic discount
martyw's Fair Value
Revenue
14% p.a.
Profit Margin
12.3%
Future PE
121.33x
Price in 2030
US$359.83
LK₨240
68.2% undervalued intrinsic discount
kalindu's Fair Value
Revenue
35.85% p.a.
Profit Margin
14%
Future PE
7x
Price in 2030
LK₨635.82
JA$59
32.1% undervalued intrinsic discount
Revenue
25.56% p.a.
Profit Margin
12.63%
Future PE
11.3x
Price in 2030
JA$131.82
LENZ logo
LENZ Therapeutics

LENZ Therapeutics - a high risk high reward small cap biotech stock

Hello Simply Wallstreet I have some DD on a small cap company I want to share. Firstly I want you all to be aware of the risks associated with small caps.Read more

View narrative
306
users have viewed this narrative
7users have liked this narrative
1users have commented on this narrative
9users have followed this narrative
US$200
91.0% undervalued intrinsic discount
Revenue
247.32% p.a.
Profit Margin
15.03%
Future PE
25.02x
Price in 2030
US$277.58